Catalyst Wire Dossier Catalyst Wire Dossier

Liposomal irinotecan

liposomal irinotecan
Drug timelines are a Plus or Pro feature.

20 regulatory and trial events tracked for Liposomal irinotecan, covering 2024-06-21 to 2026-04-24. Get the full timeline:

Most recent: Clinical Trial Update: Evaluating NALIRIFOX vs Modified Gemcitabine, Nab-Paclitaxel and Cisplatin in Patients With Locally Advanced and Metastatic Pancreatic Adenocarcinoma [Phase 2]

See pricing